CD40LG and COVID-19: The level of SARS-CoV-2 antibodies in one leukemia patient was seemingly reversed class-switch (from anti-SARS-CoV-2 IgG to IgM) after chemotherapy, while the changes of serum antibodies of the other two leukemia patients were consistent with those of COVID-19 recovered healthy people.